The Blood and Marrow Transplant Program at Northside Hospital (NH-BMT) provides the best of both worlds—clinical excellence and compassionate care. We are committed to being the premier program in the Southeast, providing exceptional, state-of-the-art care to patients undergoing acute leukemia treatment, CAR T-cell immunotherapy, and blood and marrow stem cell transplantation. New patient brochure
2024 National Leaders in Allogeneic Transplantation
NH-BMT is the ONLY BMT program in the country and the only BMT program in Georgia to have achieved survival outcomes that significantly exceeded the expected survival rate for allogeneic and unrelated donor transplants for the last 16 consecutive reporting cycles (2009–2024) and is one of only 12 national centers (less than 10% of all centers) to over-perform for the current annual reporting cycle.
The program’s actual one-year survival rate, as reported in the Center for International Blood and Marrow Transplant Research (CIBMTR) final 2024 Transplant Center Specific Survival Report, is 82.6%.*
Specific Northside Hospital transplant center information can be found at nmdp.org.*
Amtagvi (lifileucel) is now available as SECOND line therapy for patients with unresectable or metastatic melanoma
Northside’s Immunotherapy Program is the ONLY approved TIL treatment center in Georgia.
Eligibility: To schedule a patient consultation, please call The Blood & Marrow Transplant Group of Georgia at 404-255-1930.
>18 years of age with unresectable or metastatic melanoma
Must have progressed on at least 1 previous systemic therapy, including a PD-L1 antibody, and if they had BRAF V600E mutation-positive disease, a BRAF or BRAF/MEK inhibitor
At least 1 resectable lesion
Addressing bone marrow health disparities
July is recognized as African American Bone Marrow Awareness Month, an opportunity to highlight health disparities affecting Black and African American patients in need of life-saving blood stem cell and bone marrow therapies.
We asked Dr. Lizamarie Bachier, an attending physician with the Northside’s blood and marrow transplant and hematologic malignancy programs, to discuss these disparities and what can be done to increase access to treatment options and improve outcomes.
Q&A: CAR T-cell therapy
Dr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers common questions about CAR T-cell therapy and discusses its role in the treatment of cancer.
What is CAR T-cell therapy and how does it work?
Dr. Solh: CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an advanced form of cancer treatment that uses the body’s own immune system to fight cancer cells. A patient’s own T-cells are engineered to find and destroy cancer cells. When the cells are infused back into the patient, they will attack the cancer and get rid of it.
Patient Stories
Lyle’s story: Thankful for CAR T-cell therapy
With the holidays upon us, Lyle Hermann says he has a lot to be thankful for — recently adding CAR T-cell therapy to his list.
In January 2016, Lyle was diagnosed with multiple myeloma, a blood cancer that develops in plasma cells in the bone marrow; it’s similar to lymphoma and leukemia. Though he didn’t panic, he was initially surprised by the diagnosis, as he had previously been in excellent health, going for walks with his wife of more than 50 years, exercising, and playing with his two grandchildren. Click Here to read full interview
Dawn’s story: Every patient needs to have a caregiver
In late January 2020, I woke up in pain and went to urgent care, where I was then sent to the ER. I could see the doctors knew something was wrong, but they weren’t sure what my problem was. I was referred to a hematologist, and (voila!) my platelets were 15,000 — a few hundred thousand short! The diagnosis: acute lymphoblastic leukemia, or ALL.I was immediately admitted to the Blood & Marrow Transplant (BMT) Program at Northside Hospital for intensive inpatient treatment.Click Here to read full interview
How a cheek swab years earlier saves life of Atlanta pilot
Jack Miller nearly collapsed at an urgent care center after spiking a fever of 105 degrees one morning in early 2020. What the Newnan commercial airline pilot thought was merely a bad cold or the flu turned out to be far more serious.After being rushed to an emergency room, medical tests revealed Miller, who was 51 at the time, was suffering from acute myeloid leukemia, or AML. Click Here to read full interview
